Qinotto

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Macromolecule
    • Specialty Pharmaceuticals
See more in Biomedtracker

Latest on Qinotto

In Vivo

2024’s Busiest Dealmakers: Novartis Laps The Field, While Lilly, Sanofi Keep Busy

 
• By Joseph Haas

With the business year almost complete, a review of biopharmaceutical dealmaking showed that Novartis, in particular, enjoyed a very productive year with 21 transactions overall, including six acquisi

Scrip

Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MacroGenics Gets $40m Up Front For St